In Vitro Compatibility and Toxicity of Metarhizium anisopliae with Insecticides against Spodoptera litura
DOI:
https://doi.org/10.23910/2/2025.5776cKeywords:
Compatibility, insecticides, Metarhizium anisopliae, Spodoptera litura, toxicityAbstract
The present investigation was conducted during June, 2022 to January, 2023 at Dr. Panjabrao Deshmukh Krishi Vidyapeeth, Akola (MH) to examine the compatibility of M. anisopliae with insecticides by poison food technique in completely randomized design. The data on colony diameter of M. anisopliae in each treatment was collected at 10 days after inoculation. Among the insecticides tested, Chlorantraniliprole 18.50% SC (0.006%) exhibited minimum inhibitory effect on M. anisopliae and proved most compatible insecticide tested against M. anisopliae, stood at par with M. anisopliae alone. It was followed by treatment Chlorantraniliprole 9.30%+λ-cyhalothrin 4.60% ZC (0.007%), Thiamethoxam 25% WG (0.003%), Thiamethoxam 12.60%+λ-cyhalothrin 9.50% ZC (0.009%), λ-cyhalothrin 5% EC (0.005%). However, all the insecticidal treatments proved “harmless” as per Hassan (1989) and were compatible with M. anisopliae. Besides, the experiment was performed to assess the toxicity of M. anisopliae alone and in combination with insecticides at half the recommended concentration against third instar larvae of Spodoptera litura by leaf dip bioassay. The observations on mortality of larvae of S. litura were recorded at 3, 7 and 10 days after treatment. At 10 days after treatment, Chlorantraniliprole 18.50% SC (0.003%)+M. anisopliae and Chlorantraniliprole 9.30%+λ-cyhalothrin 4.60 % ZC (0.0035%)+M. anisopliae caused promising larval mortality of cent per cent each. The combination of M. anisopliae with insecticides at half the recommended dose led to higher mortality of the S. litura.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 PP House

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles published are made available as open access articles, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
This journal permits and encourages authors to share their submitted versions (preprints), accepted versions (postprints) and/or published versions (publisher versions) freely under the CC BY-NC-SA 4.0 license while providing bibliographic details that credit, if applicable.